Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.665
+0.265 (7.79%)
Jul 2, 2025, 3:26 PM - Market open
Aquestive Therapeutics Employees
Aquestive Therapeutics had 142 employees as of December 31, 2024. The number of employees increased by 7 or 5.19% compared to the previous year.
Employees
142
Change (1Y)
7
Growth (1Y)
5.19%
Revenue / Employee
$381,887
Profits / Employee
-$381,965
Market Cap
364.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
AQST News
- 7 days ago - Aquestive Therapeutics: Updating The Anaphylm Timeline To Approval - Seeking Alpha
- 7 days ago - Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit - GlobeNewsWire
- 23 days ago - Aquestive Therapeutics: Anaphylm Could Gain Significant Market Share - Seeking Alpha
- 7 weeks ago - Aquestive Therapeutics, Inc. (AQST) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Aquestive Therapeutics: Unprofitable For A Few More Years, But Significant Upside Potential - Seeking Alpha
- 2 months ago - Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET - GlobeNewsWire
- 3 months ago - Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium - GlobeNewsWire